CD34 and acute myeloid leukemia: Additionally, inhibition or knockdown of SPHK1/SPHK1 led to lower survival of primary AML blasts, while importantly, SPHK1 inhibition in normal CD34+ cells did not exert the same effect, confirming SPHK1 dysregulation as a player in leukemic cell survival [145].